Results 321 to 330 of about 8,237,739 (337)

Developing and Testing Electronic Versions of the Advance QoL Tools for Collecting Self-Reports of Quality of Life in Children and Adolescents With Advanced Cancer. [PDF]

Scand J Caring Sci
Robichaud LA, Guarascio N, Duval M, Michon B, Olivier-D'Avignon M, Tyo-Gomez M, Rondeau É, Marquis MA, Sultan S.   +8 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung Cancer. [PDF]

Mol Cancer Ther
Deng S, Hussain T, Bartelli TF, Sebastian MM, Zarghooni M, Velasco WV, Somerville B, Phan L, Savage MI, Song Y, Clifford JL, Kadara H, McAllister F, Brown PH, Moghaddam SJ, Aldaz CM.   +15 more
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Development and pilot testing of AYA-RISE, a risk information and screening education intervention for adolescents and young adults with cancer risk syndromes. [PDF]

Fam Cancer
Kamihara J, Fisher L, Schienda J, Vanderwall R, Snir M, Snir G, Simmons E, Khalaj A, Goler E, Hamilton KV, Porter CC, Pencheva B, Schiffman JD, Maese LD, Kohlmann W, Henderson TO, Garber JE, Diller LR, Desai AV, Savage S, Klosky JL, Rana HQ, Mack JW.   +22 more
europepmc   +1 more source

Contesting the C Word: The Diagnosis of DCIS and Women's Resistance Against Overtreatment. [PDF]

Sociol Health Illn
Gu CJ.
europepmc   +1 more source

Material and Administrative Components of Financial Toxicity and Survivorship Well-Being: A Cross-Sectional Analysis of HINTS (2012-2017). [PDF]

Cancer Med
Wu IHC, Harris SR, Price R, Bista S.
europepmc   +1 more source

Association of patient-generated subjective global assessment (PG-SGA) scores with survival outcomes in cancer patients: A systematic review and meta-analysis. [PDF]

Asia Pac J Clin Nutr
Wu H, Fan Y, Cheng J, Li X, Zhao Q, Hu A, Zhang B.   +6 more
europepmc   +1 more source

Research progress on vasculogenic mimicry in colorectal cancer: mechanisms and therapeutic. [PDF]

Cell Div
Zewei J, Haiyan Z.
europepmc   +1 more source